Overview

Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis

Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
To see if using teriparatide for 12 months will increase Bone Mineral Density at the lumbar spine in postmenopausal women with osteoporosis
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Teriparatide